DUBLIN, Calif., Nov. 13 SuperGen, Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery anddevelopment of novel cancer therapies, today announced that James S. Manuso,Ph.D., President and Chief Executive Officer is scheduled to present at theFifth Annual Lazard Healthcare Conference on Tuesday, November 18, 2008 at theSt. Regis in New York, New York.
SuperGen's presentation at the Lazard Healthcare Conference is scheduledto begin at 4:40 p.m. EDT (1:40 p.m. PDT). A live webcast of the presentationwill be available on the investor relations section of the Company's Web siteat www.supergen.com. The webcast will be archived for 90 days.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery and development of novel cancer therapies. SuperGenis developing a number of therapeutic anticancer products focused on kinaseand cell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit www.supergen.com.Contacts: SuperGen, Inc. Dorland Global Public Relations Timothy L. Enns Michael Beckerich (Media) SVP, Corporate Communications Tel: (212) 677-7632 & Business Development [email protected]
Tel: (925) 560-2810 Email: [email protected]
SOURCE SuperGen, Inc.